Regulatory role of CD4+CD25+Foxp3+ regulatory T cells on IL-17-secreting T cells in chronic hepatitis B patients

Digestive Diseases and Sciences

Volumn 59, Issue 7, 2014, Pages 1475-1483

  Li, Jie ^a   Shi, Jun ^a   Ren, Wanhua ^a   Wu, Wei ^b   Chen, Zhi ^b  

^a SHANDONG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Antigen specific; Hepatitis B virus; IL 17 secreting T cells; Regulation

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; INTERLEUKIN 17;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN EXPRESSION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FOXP3+ REGULATORY T LYMPHOCYTE; HEPATITIS B; HUMAN; IMMUNOSTIMULATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH17 CELL;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; MALE; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84903543097     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-3022-1     Document Type: Article

References (41)

1. Manigold T, Racanelli V. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect Dis. 2007;7:804-813. (Pubitemid 350152043)
2. McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis. 2005;25:3-8. (Pubitemid 41254588)
3. Rehermann B. Intrahepatic T cells in hepatitis B: viral control versus liver cell injury. J Exp Med. 2000;191:1263-1268. (Pubitemid 30227115)
4. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005;5:215-229. (Pubitemid 40364823)
5. Peng G, Li S, Wu W, Sun Z, Chen Y, Chen Z. Circulating CD4+CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology. 2008;123:57-65. (Pubitemid 350255997)
6. Rowan AG, Fletcher JM, Ryan EJ, et al. Hepatitis C virus-specific TH17 cells are suppressed by virus-induced TGF-beta. J Immunol. 2008;181:4485-4494.
7. Boissier MC, Assier E, Falgarone G, Bessis N. Shifting the imbalance from Th1/Th2 to Th17/Treg: the changing rheumatoid arthritis paradigm. Joint Bone Spine. 2008;75:373-375.
8. Oboki K, Ohno T, Saito H, Nakae S. Th17 and allergy. Allergol Int. 2008;57:121-134. (Pubitemid 351897666)
9. Kikly K, Liu L, Na S, Sedgwick JD. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr Opin Immunol. 2006;18:670-675. (Pubitemid 44635178)
10. Wu W, Li J, Chen F, Zhu H, Peng G, Chen Z. Circulating TH17 cells frequency is associated with the disease progression in HBV infected patients. J Gastroenterol Hepatol. 2010;25:750-757.
11. Zhang JY, Zhang Z, Lin F, et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2010;51:81-91.
12. Zhang F, Yao S, Yuan J, et al. Elevated IL-6 receptor expression on CD4+ T cells contributes to the increased Th17 responses in patients with chronic hepatitis B. Virol J. 2011;8:270.
13. Gao L, Wang JF, Xiang M, Fan YC, Zhang ZG, Wang K. Expression of human glucocorticoid receptor in T lymphocytes in acute-on-chronic hepatitis B liver failure. Dig Dis Sci. 2011;56:2605-2612.
14. Xue-Song L, Cheng-Zhong L, Ying Z, Mo-Bin W. Changes of treg and th17 cells balance in the development of acute and chronic hepatitis B virus infection. BMC Gastroenterol. 2012;12:43.
15. Li J, Qiu SJ, She WM, et al. Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis. PLoS One. 2012;7:e39307.
16. Chinese Society of Infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Association. Chinese medicine national program for prevention and treatment of viral hepatitis. Chin J Hepatol. 2011;19:13-24.
17. Li J, Wu W, Peng G, et al. Hbcag induces interleukin-10 production, inhibiting Hbcag-specific th17 responses in chronic hepatitis b patients. Immunol Cell Biol. 2010;88:834-841.
18. Yang B, Wang Y, Zhao C, et al. Increased Th17 cells and interleukin-17 contribute to immune activation and disease aggravation in patients with chronic hepatitis B virus infection. Immunol Lett. 2013;149:41-49.
19. Lafdil F, Miller AM, Ki SH, Gao B. Th17 cells and their associated cytokines in liver diseases. Cell Mol Immunol. 2010;7:250-254.
20. Xu D, Fu J, Jin L, et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol. 2006;177:739-747. (Pubitemid 43939189)
21. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol. 2005;6:353-360. (Pubitemid 41716772)
22. Bouchliou I, Miltiades P, Nakou E, et al. Th17 and Foxp3(+) T regulatory cell dynamics and distribution in myelodysplastic syndromes. Clin Immunol. 2011;139:350-359.
23. Li N, Bian H, Zhang J, Li X, Ji X, Zhang Y. The Th17/Treg imbalance exists in patients with heart failure with normal ejection fraction and heart failure with reduced ejection fraction. Clin Chim Acta. 2010;411:1963-1968.
24. Li J, Wang L, Wang S, et al. The Treg/Th17 imbalance in patients with idiopathic dilated cardiomyopathy. Scand J Immunol. 2010;71:298-303.
25. Wang Q, Zheng Y, Huang Z, et al. Activated IL-23/IL-17 pathway closely correlates with increased Foxp3 expression in livers of chronic hepatitis B patients. BMC Immunol. 2011;12:25.
26. Evans HG, Suddason T, Jackson I, Taams LS, Lord GM. Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of toll-like receptor-activated monocytes. Proc Natl Acad Sci USA. 2007;104:17034-17039. (Pubitemid 350210986)
27. Xu L, Kitani A, Fuss I, Strober W. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3-T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol. 2007;178:6725-6729. (Pubitemid 46847395)
28. Weaver CT, Hatton RD. Interplay between the Th17 and Treg cell lineages: a (co-)evolutionary perspective. Nat Rev Immunol. 2009;9:883-889.
29. Zhou L, Lopes JE, Chong MM, et al. TGF-beta-induced Foxp3 inhibits T(h)17 cell differentiation by antagonizing RORgammat function. Nature. 2008;453:236-240. (Pubitemid 351667978)
30. Du J, Huang C, Zhou B, Ziegler SF. Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human Foxp3. J Immunol. 2008;180:4785-4792.
31. Ichiyama K, Yoshida H, Wakabayashi Y, et al. Foxp3 inhibits RORgammat-mediated IL-17a Mrna transcription through direct interaction with RORgammat. J Biol Chem. 2008;283:17003-17008.
32. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature. 2006;441:235-238.
33. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006;24:179-189. (Pubitemid 43214587)
34. Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005;201:233-240. (Pubitemid 40189432)
35. Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126:1121-1133. (Pubitemid 44380299)
36. Dambacher J, Beigel F, Zitzmann K, et al. The role of interleukin-22 in hepatitis c virus infection. Cytokine. 2008;41:209-216.
37. Huber M, Heink S, Grothe H, et al. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity. Eur J Immunol. 2009;39:1716-1725.
38. Hamada H, de la Luz Garcia-Hernandez M, Reome JB, et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol. 2009;182:3469-3481.
39. Burrell BE, Csencsits K, Lu G, Grabauskiene S, Bishop DK. Cd8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice. J Immunol. 2008;181:3906-3914.
40. Tajima M, Wakita D, Noguchi D, et al. Il-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+ T cells. J Exp Med. 2008;205:1019-1027. (Pubitemid 351679678)
41. Yen HR, Harris TJ, Wada S, et al. Tc17 CD8 T cells: functional plasticity and subset diversity. J Immunol. 2009;183:7161-7168.